JP2020536643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536643A5 JP2020536643A5 JP2020520207A JP2020520207A JP2020536643A5 JP 2020536643 A5 JP2020536643 A5 JP 2020536643A5 JP 2020520207 A JP2020520207 A JP 2020520207A JP 2020520207 A JP2020520207 A JP 2020520207A JP 2020536643 A5 JP2020536643 A5 JP 2020536643A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- visual stimulus
- chronic visual
- frequency
- current signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001684 chronic Effects 0.000 claims 72
- 230000000007 visual effect Effects 0.000 claims 72
- 210000004556 Brain Anatomy 0.000 claims 35
- 210000002442 Prefrontal Cortex Anatomy 0.000 claims 34
- 210000001320 Hippocampus Anatomy 0.000 claims 32
- 210000000857 Visual Cortex Anatomy 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 230000001537 neural Effects 0.000 claims 6
- 230000001360 synchronised Effects 0.000 claims 6
- 210000004092 Somatosensory Cortex Anatomy 0.000 claims 5
- 230000005684 electric field Effects 0.000 claims 5
- 206010001897 Alzheimer's disease Diseases 0.000 claims 4
- 206010012289 Dementia Diseases 0.000 claims 4
- 210000002569 neurons Anatomy 0.000 claims 4
- 230000032258 transport Effects 0.000 claims 4
- 231100000277 DNA damage Toxicity 0.000 claims 3
- 210000000274 Microglia Anatomy 0.000 claims 3
- 230000006907 apoptotic process Effects 0.000 claims 3
- 210000003008 brain-resident macrophage Anatomy 0.000 claims 3
- 230000010189 intracellular transport Effects 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 230000003959 neuroinflammation Effects 0.000 claims 3
- 108091005965 phosphorylated proteins Proteins 0.000 claims 3
- 238000006366 phosphorylation reaction Methods 0.000 claims 3
- 230000000865 phosphorylative Effects 0.000 claims 3
- 230000003977 synaptic function Effects 0.000 claims 3
- 210000004940 Nucleus Anatomy 0.000 claims 2
- 238000009825 accumulation Methods 0.000 claims 2
- 230000002708 enhancing Effects 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 206010003694 Atrophy Diseases 0.000 claims 1
- 102000008491 Dynamins Human genes 0.000 claims 1
- 108010020522 Dynamins Proteins 0.000 claims 1
- 102000037108 Glutamate transporters Human genes 0.000 claims 1
- 108091006135 Glutamate transporters Proteins 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 210000000225 Synapses Anatomy 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000002730 additional Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000000051 modifying Effects 0.000 claims 1
- 230000002314 neuroinflammatory Effects 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 230000002797 proteolythic Effects 0.000 claims 1
- 230000001131 transforming Effects 0.000 claims 1
- 230000002861 ventricular Effects 0.000 claims 1
Claims (82)
A)約30Hz〜約50Hzの周波数を有する慢性視覚刺激を前記対象に非侵襲的に送達し、前記対象の少なくとも前頭前野皮質(PFC)および海馬を含む、前記対象の複数の脳領域において同期化ガンマ振動を同調させることを含む、前記方法。 A method for treating dementia or Alzheimer's disease in the subject in need.
A) A chronic visual stimulus with a frequency of about 30 Hz to about 50 Hz is delivered non-invasively to the subject and synchronized in multiple brain regions of the subject, including at least the prefrontal cortex (PFC) and hippocampus of the subject. comprising tuning the gamma vibration, said method.
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項6に記載の方法。 The method of claim 6, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項10に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
10. The method of claim 10, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A1)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を前記対象に非侵襲的に送達し、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域において同期化ガンマ振動を同時に同調させることを含む、請求項1に記載の方法。 A),
A1) The chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz is delivered non-invasively to the subject and synchronized in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject. The method of claim 1, comprising tuning gamma vibrations simultaneously.
前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の複数の脳領域間で、30Hz〜50Hzの周波数を有するガンマコヒーレンスを有意に増加させることを含む、請求項15に記載の方法。 A1),
15. The method of claim 15, comprising significantly increasing gamma coherence having a frequency of 30 Hz to 50 Hz among the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項22に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
22. The method of claim 22, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A2)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域間のニューロン活動を変調させることを含む、請求項15に記載の方法。 A1) is further
A2) Non-invasively deliver the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to perform neuronal activity between the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject. 15. The method of claim 15, comprising modulating.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域間のニューロン活動を連動させることを含む、請求項24に記載の方法。 A2) is further
The chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz is non-invasively delivered to link neuronal activity between the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject. 24. The method of claim 24.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項27に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
27. The method of claim 27, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A3)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の神経変性を低下させることを含む、請求項24に記載の方法。 A2) is further
A3) Non-invasively deliver the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to degenerate neurodegeneration in the subject's multiple brain regions, including at least the prefrontal cortex and hippocampus of the subject. 24. The method of claim 24, comprising reducing.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中のアミロイドプラークを低下させることを含む、請求項33に記載の方法。 A3) is even more
The chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz is non-invasively delivered to reduce amyloid plaques in the subject's plurality of brain regions, including at least the prefrontal cortex and hippocampus of the subject. 33. The method of claim 33.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中のタウの過剰リン酸化を低下させることを含む、請求項33に記載の方法。 A3) is even more
Excessive phosphorylation of tau in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject, non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz. 33. The method of claim 33, comprising reducing.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中のニューロンおよびシナプスの減少を低下させることを含む、請求項33に記載の方法。 A3) is even more
Non-invasive delivery of the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to reduce neurons and synapses in the subject's plurality of brain regions, including at least the prefrontal cortex and hippocampus of the subject. 33. The method of claim 33, comprising reducing.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の脳委縮を低下させることを含む、請求項33に記載の方法。 A3) is even more
The chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz is non-invasively delivered to reduce brain atrophy in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject. 33. The method of claim 33.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の脳室拡張を低下させることを含む、請求項33に記載の方法。 A3) is even more
Non-invasively deliver the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to reduce ventricular dilation in the subject's plurality of brain regions, including at least the prefrontal cortex and hippocampus of the subject. 33. The method of claim 33.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項41に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
41. The method of claim 41, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項45に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
45. The method of claim 45, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A3)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の神経炎症を低下させることを含む、請求項24に記載の方法。 A2) is further
A3) Non-invasively deliver the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to cause neuroinflammation in the subject's multiple brain regions, including at least the prefrontal cortex and hippocampus of the subject. 24. The method of claim 24, comprising reducing.
A4)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の少なくとも一部のミクログリアの免疫反応を低下させることを含む、請求項47に記載の方法。 A3) is even more
A4) At least a portion of the subject's multiple brain regions, including at least the prefrontal cortex and hippocampus of the subject, non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz. 47. The method of claim 47, comprising reducing the immune response of microglia.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の前記少なくとも一部のミクログリアを形態変換させることを含む、請求項48に記載の方法。 A4) is further
Non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz, said at least a portion of the subject's plurality of brain regions, including at least the prefrontal cortex and hippocampus of the subject. 48. The method of claim 48, comprising morphologically transforming microglia.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の前記少なくとも一部のミクログリアにおいてタンパク質分解を増加させることを含む、請求項48に記載の方法。 A4) is further
Non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz, said at least a portion of the subject's plurality of brain regions, including at least the prefrontal cortex and hippocampus of the subject. 48. The method of claim 48, comprising increasing proteolysis in microglia.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項53に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
53. The method of claim 53, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の膜輸送、細胞内輸送、シナプス機能、神経炎症、アポトーシスプロセス、およびDNA損傷のうちの少なくとも一つに関与する異常改変された遺伝子およびタンパク質を改善することを含む、請求項24に記載の方法。 A2) is further
Non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz, membrane transport, intracellular transport within the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject. 24. The method of claim 24, comprising ameliorating aberrantly modified genes and proteins involved in at least one of transport, synaptic function, neuroinflammatory, apoptotic processes, and DNA damage.
A2)前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の学習および記憶を強化することを含む、請求項15に記載の方法。 A1) is further
A2) The method of claim 15, comprising non-invasively delivering the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to enhance learning and memory of the subject.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項59に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
59. The method of claim 59, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A)約30Hz〜約50Hzの周波数を有する慢性視覚刺激を前記対象に非侵襲的に送達し、前記対象の少なくとも前頭前野皮質(PFC)および海馬を含む、前記対象の複数の脳領域において同期化ガンマ振動を同調させることを含み、A)が、前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を、前記対象に非侵襲的に送達して、
A1)前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域において同期化ガンマ振動を同時に同調させること、
A2)前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域間のニューロン活動を連動させること、
A3)前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の神経変性を低下させること、
A4)前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の神経炎症を低下させること、
A5)前記対象の少なくとも前頭前野皮質および海馬を含む、前記対象の前記複数の脳領域中の膜輸送、細胞内輸送、シナプス機能、神経炎症、アポトーシスプロセス、およびDNA損傷のうちの少なくとも一つに関与する異常改変された遺伝子およびタンパク質を改善すること、および
A5)前記対象の学習および記憶を強化すること、を含む、前記方法。 A method for treating dementia or Alzheimer's disease in the subject in need.
A) A chronic visual stimulus with a frequency of about 30 Hz to about 50 Hz is delivered non-invasively to the subject and synchronized in multiple brain regions of the subject, including at least the prefrontal cortex (PFC) and hippocampus of the subject. A) non-invasively delivers the chronic visual stimulus having a frequency of about 30 Hz to about 50 Hz to the subject, comprising tuning gamma vibrations.
A1) Simultaneously synchronizing synchronized gamma oscillations in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject.
A2) Linking neuronal activity between the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject.
A3) To reduce neurodegeneration in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject.
A4) To reduce neural inflammation in the plurality of brain regions of the subject, including at least the prefrontal cortex and hippocampus of the subject.
A5) For at least one of membrane transport, intracellular transport, synaptic function, neuroinflammation, apoptotic process, and DNA damage in the subject's multiple brain regions, including at least the prefrontal cortex and hippocampus of the subject. improving the involvement abnormally altered genes and proteins, and A5) to enhance learning and memory of the object, including the method.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項63に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
63. The method of claim 63, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項61に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
61. The method of claim 61, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A)約30Hz〜約50Hzの周波数を有する慢性視覚刺激を前記対象に非侵襲的に送達し、前記対象の複数の脳領域において同期化ガンマ振動を同調させ、前記対象の複数の脳領域において変性ニューロン中の異常改変された遺伝子およびタンパク質を改善することを含み、
前記対象の前記複数の脳領域において、前記変性ニューロン中の前記異常改変された遺伝子およびタンパク質が、膜輸送、細胞内輸送、シナプス機能、神経炎症、アポトーシスプロセス、およびDNA損傷のうちの少なくとも一つに関与し、
前記異常改変された遺伝子およびタンパク質が、S/Tリン酸化タンパク質を含み、
A)が、前記慢性視覚刺激を非侵襲的に送達して、前記S/Tリン酸化タンパク質を改変し、前記対象の少なくとも視覚皮質中のS/Tリン酸化を低下させることをさらに含む、
前記方法。 A method for treating dementia or Alzheimer's disease in the subject in need.
A) A chronic visual stimulus with a frequency of about 30 Hz to about 50 Hz is delivered non-invasively to the subject, synchronized gamma oscillations are tuned in the subject's multiple brain regions, and degeneration in the subject's multiple brain regions. see contains at improving abnormal altered genes and proteins in neurons,
In the plurality of brain regions of the subject, the abnormally modified gene and protein in the degenerated neuron is at least one of membrane transport, intracellular transport, synaptic function, neuroinflammation, apoptotic process, and DNA damage. Involved in
The aberrantly modified gene and protein comprises an S / T phosphorylated protein.
A) further comprises non-invasively delivering the chronic visual stimulus to modify the S / T phosphorylated protein and reduce S / T phosphorylation in at least the visual cortex of the subject.
The method.
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、請求項75に記載の方法。 A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
75. The method of claim 75, wherein the square wave current signal has a 50% load cycle and the frequency of the square wave current signal is equal to or approximately 40 Hz.
A)約30Hz〜約50Hzの周波数を有する慢性視覚刺激を、少なくとも42日間、少なくとも1日あたり1時間前記対象に非侵襲的に送達し、前記対象の複数の脳領域において同期化ガンマ振動を同時に同調させ、前記対象の前記複数の脳領域の間で、前記30Hz〜50Hzの周波数を有するガンマコヒーレンスを有意に増加させることを含み、
A)が、矩形波電流シグナルを伴う発光ダイオード(LED)のアレイを駆動させ、前記慢性視覚刺激を生成することをさらに含み、
前記矩形波電流シグナルが、50%負荷サイクルを有し、および
前記矩形波電流シグナルの周波数が、40Hzと等しいか、またはおよそ40Hzである、
前記方法。 A method for treating dementia or Alzheimer's disease in the subject in need.
A) Chronic visual stimuli with frequencies of about 30 Hz to about 50 Hz are delivered non-invasively to the subject for at least 42 days, at least 1 hour per day, and simultaneous synchronized gamma oscillations in multiple brain regions of the subject. tuned, among the plurality of brain regions of the object, seen including to increase significantly the gamma coherence with the frequency of the 30Hz~50Hz,
A) further comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimulus.
The square wave current signal has a 50% load cycle and
The frequency of the square wave current signal is equal to or approximately 40 Hz.
The method.
前記約30Hz〜約50Hzの周波数を有する前記慢性視覚刺激を非侵襲的に送達して、前記対象の前記複数の脳領域間のニューロン活動を連動させることを含む、請求項77に記載の方法。 A) is further
The chronic visual stimuli delivered noninvasively, causing interlocking neuronal activities between the multiple brain regions of the object, method according to claim 77 having a frequency of the about 30Hz~ about 50 Hz.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762570250P | 2017-10-10 | 2017-10-10 | |
US62/570,250 | 2017-10-10 | ||
US201762570929P | 2017-10-11 | 2017-10-11 | |
US62/570,929 | 2017-10-11 | ||
PCT/US2018/051785 WO2019074637A1 (en) | 2017-10-10 | 2018-09-19 | Systems and methods for preventing, mitigating, and/or treating dementia |
USPCT/US2018/051785 | 2018-09-19 | ||
PCT/US2018/055258 WO2019075094A1 (en) | 2017-10-10 | 2018-10-10 | Treating dementia with visual stimulation to synch gamma oscillations in brain |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020536643A JP2020536643A (en) | 2020-12-17 |
JP2020536643A5 true JP2020536643A5 (en) | 2021-11-18 |
Family
ID=83459525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020520207A Pending JP2020536643A (en) | 2017-10-10 | 2018-10-10 | Treatment of dementia with visual stimuli that synchronize gamma oscillations in the brain |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3694593A4 (en) |
JP (1) | JP2020536643A (en) |
KR (2) | KR20200086277A (en) |
CN (1) | CN111655319A (en) |
AU (2) | AU2018347366B2 (en) |
CA (1) | CA3078739A1 (en) |
WO (1) | WO2019075094A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4045139A1 (en) | 2019-10-18 | 2022-08-24 | Institute of Science and Technology Austria | Stimulation of neuronal plasticity |
KR20210053631A (en) * | 2019-11-04 | 2021-05-12 | 한국과학기술원 | Method of entraining gamma brain wave using visible light and apparatus for providing visible stimulation |
KR102400319B1 (en) * | 2021-12-31 | 2022-05-24 | (주)리솔 | Apparatus and Method for Stimulating a Brain by Entraining Synchronized Vibration in a Plurality of Brain Regions of a User |
KR102425066B1 (en) * | 2022-03-25 | 2022-07-28 | (주)리솔 | Customized tACS (transcranial Alternating Current Stimulation) Apparatus and Method for Stimulating a Brain wave by Entraining Synchronized Oscillation Based on Real-Time EEG Signal Monitoring |
KR102577515B1 (en) | 2022-11-21 | 2023-09-12 | 이종설 | Wave stimulator for cell activation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125298A1 (en) * | 1991-12-06 | 1993-06-10 | Eva-Maria Mandelkow | Tools for the diagnosis and treatment of alzheimer's disease |
JP3648802B2 (en) * | 1994-09-27 | 2005-05-18 | 松下電工株式会社 | High intensity light irradiation device for phototherapy |
JP2008520280A (en) * | 2004-11-15 | 2008-06-19 | デチャームス,クリストファー | Application of nerve tissue stimulation using light |
US20080181882A1 (en) * | 2006-11-15 | 2008-07-31 | The University Of Pennsylvania | Neurgulin 1 (NRG1) - ErbB4 signaling as a target for the treatment of schizophrenia |
WO2008147958A1 (en) * | 2007-05-25 | 2008-12-04 | Thomas Jefferson University | Method of treatment to improve concentration and/or memory in a subject in need thereof |
DE102008012669B8 (en) * | 2008-03-05 | 2011-03-03 | Anm Adaptive Neuromodulation Gmbh | Apparatus and method for visual stimulation |
ITRM20090027A1 (en) * | 2009-01-26 | 2010-07-27 | Alain Rocco | STIMULATION SYSTEM FOR PAIN TREATMENT AND ITS FUNCTIONING METHOD. |
WO2012024243A1 (en) * | 2010-08-16 | 2012-02-23 | Photothera, Inc. | Minimally invasive low level light therapy for neurological disorders |
US20140296945A1 (en) * | 2011-10-25 | 2014-10-02 | Kanazawa Medical University | Light irradiation device for improving cognitive symptom and depression symptom, room having the light irradiation device, and lighting device for improving cognitive symptom and depression symptom |
US9272118B1 (en) * | 2012-03-02 | 2016-03-01 | George Acton | Methods for treating brain malfunctions |
US20150337030A1 (en) * | 2012-05-31 | 2015-11-26 | The Trustees Of Columbia University In The City Of New York | Methods to treat alzheimer's disease using apoe inhibitors |
US20140303025A1 (en) * | 2013-03-15 | 2014-10-09 | The Translational Genomics Research Institute | Methods for the diagnosis and prognosis of neurodegenerative diseases |
US10625042B2 (en) * | 2013-11-04 | 2020-04-21 | Phoenix Neurostim Therapeutics, Llc | Treatment of central nervous system conditions using sensory stimulus |
WO2015149170A1 (en) * | 2014-03-31 | 2015-10-08 | Functional Neuromodulation, Inc. | Systems and methods for determining a trajectory for a brain stimulation lead |
WO2016023126A1 (en) * | 2014-08-14 | 2016-02-18 | Functional Neuromodulation, Inc. | Brain stimulation system including multiple stimulation modes |
EP3383482B1 (en) * | 2015-11-24 | 2023-01-04 | Massachusetts Institute of Technology | Systems for preventing, mitigating, and/or treating dementia |
WO2017172728A1 (en) * | 2016-03-28 | 2017-10-05 | Duke University | Systems and methods for brain stimulation |
-
2018
- 2018-10-10 KR KR1020207013291A patent/KR20200086277A/en not_active Application Discontinuation
- 2018-10-10 EP EP18866752.1A patent/EP3694593A4/en active Pending
- 2018-10-10 JP JP2020520207A patent/JP2020536643A/en active Pending
- 2018-10-10 CA CA3078739A patent/CA3078739A1/en active Pending
- 2018-10-10 WO PCT/US2018/055258 patent/WO2019075094A1/en unknown
- 2018-10-10 CN CN201880077874.3A patent/CN111655319A/en active Pending
- 2018-10-10 KR KR1020237001501A patent/KR20230015501A/en not_active Application Discontinuation
- 2018-10-10 AU AU2018347366A patent/AU2018347366B2/en active Active
-
2022
- 2022-11-15 AU AU2022271389A patent/AU2022271389A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020536643A5 (en) | ||
Skipper-Kallal et al. | Right hemisphere remapping of naming functions depends on lesion size and location in poststroke aphasia | |
Grefkes et al. | Reorganization of cerebral networks after stroke: new insights from neuroimaging with connectivity approaches | |
Kim et al. | A network approach for modulating memory processes via direct and indirect brain stimulation: toward a causal approach for the neural basis of memory | |
Beuter et al. | Closed-loop cortical neuromodulation in Parkinson’s disease: An alternative to deep brain stimulation? | |
Roostaei et al. | The human cerebellum: a review of physiologic neuroanatomy | |
Notturno et al. | Local and remote effects of transcranial direct current stimulation on the electrical activity of the motor cortical network | |
Popovych et al. | Control of neuronal synchrony by nonlinear delayed feedback | |
Shin et al. | Neurostimulation for traumatic brain injury: A review | |
Popovych et al. | Control of abnormal synchronization in neurological disorders | |
Gallea et al. | Orthostatic tremor: a cerebellar pathology? | |
Moustafa et al. | The thalamus as a relay station and gatekeeper: relevance to brain disorders | |
Kibleur et al. | Electroencephalographic correlates of low-frequency vagus nerve stimulation therapy for Crohn’s disease | |
Altinay et al. | Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder | |
US20140323924A1 (en) | Targeted optogenetic neuromodulation for treatment of clinical conditions | |
Hartmann et al. | Distinct cortical responses evoked by electrical stimulation of the thalamic ventral intermediate nucleus and of the subthalamic nucleus | |
Huang et al. | Age-related differences in reorganization of functional connectivity for a dual task with increasing postural destabilization | |
Hu et al. | Controlling absence seizures by deep brain stimulus applied on substantia nigra pars reticulata and cortex | |
Pfeifer et al. | Coordinated reset vibrotactile stimulation induces sustained cumulative benefits in Parkinson’s disease | |
Basile et al. | Direct stimulation of the autonomic nervous system modulates activity of the brain at rest and when engaged in a cognitive task | |
Danilov et al. | Emerging noninvasive neurostimulation technologies: CN-NINM and SYMPATOCORECTION | |
Schutter | Human cerebellum in motivation and emotion | |
Casanova | Cortical organization: anatomical findings based on systems theory | |
Zibly et al. | Modulation of mind: therapeutic neuromodulation for cognitive disability | |
Bice et al. | Homotopic contralesional excitation suppresses spontaneous circuit repair and global network reconnections following ischemic stroke |